# Bank of New York Mellon Corp: financial statements, quarterly

BNY · NYSE · CIK 1390777 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bny.md) · [Financials](/companies/bny/financials.md) · [Filings](/companies/bny/filings.md) · [Insiders](/companies/bny/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bny/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [4,503](/filings/0001390777-23-000103.md) | [4,862](/filings/0001390777-24-000075.md) | [5,056](/filings/0001390777-24-000075.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [285](/filings/0001390777-24-000133.md) | [73.0](/filings/0001390777-24-000075.md) | [297](/filings/0001390777-25-000084.md) | [357](/filings/0001390777-25-000118.md) | [336](/filings/0001390777-25-000159.md) | [315](/filings/0001390777-25-000084.md) | [300](/filings/0001390777-26-000060.md) | [404](/filings/0001390777-26-000086.md) | [395](/filings/0001390777-25-000159.md) | [376 d](/filings/0001390777-26-000033.md) | [386](/filings/0001390777-26-000060.md) | [475](/filings/0001390777-26-000086.md) |
| Net income | $m | [1,040](/filings/0001390777-24-000133.md) | [208](/filings/0001390777-24-000075.md) | [1,025](/filings/0001390777-25-000084.md) | [1,168](/filings/0001390777-25-000118.md) | [1,182](/filings/0001390777-25-000159.md) | [1,155](/filings/0001390777-25-000084.md) | [1,220](/filings/0001390777-26-000060.md) | [1,423](/filings/0001390777-26-000086.md) | [1,445](/filings/0001390777-25-000159.md) | [1,461 d](/filings/0001390777-26-000033.md) | [1,632](/filings/0001390777-26-000060.md) | [1,761](/filings/0001390777-26-000086.md) |
| Diluted EPS | $ per share | [1.23](/filings/0001390777-24-000133.md) | [0.21](/filings/0001390777-24-000075.md) | [1.25](/filings/0001390777-25-000084.md) | [1.52](/filings/0001390777-25-000118.md) | [1.50](/filings/0001390777-25-000159.md) | [1.54](/filings/0001390777-25-000084.md) | [1.58](/filings/0001390777-26-000060.md) | [1.93](/filings/0001390777-26-000086.md) | [1.88](/filings/0001390777-25-000159.md) | not reported | [2.24](/filings/0001390777-26-000060.md) | [2.45](/filings/0001390777-26-000086.md) |
| Basic EPS | $ per share | [1.23](/filings/0001390777-24-000133.md) | [0.21](/filings/0001390777-24-000075.md) | [1.26](/filings/0001390777-25-000084.md) | [1.53](/filings/0001390777-25-000118.md) | [1.51](/filings/0001390777-25-000159.md) | [1.56](/filings/0001390777-25-000084.md) | [1.59](/filings/0001390777-26-000060.md) | [1.95](/filings/0001390777-26-000086.md) | [1.90](/filings/0001390777-25-000159.md) | not reported | [2.26](/filings/0001390777-26-000060.md) | [2.47](/filings/0001390777-26-000086.md) |

- Revenue: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [4.9](/filings/0001390777-24-000133.md) | [4.9](/filings/0001390777-26-000033.md) | [5.3](/filings/0001390777-25-000084.md) | [5.3](/filings/0001390777-25-000118.md) | [6.2](/filings/0001390777-25-000159.md) | [4.2](/filings/0001390777-26-000033.md) | [5.4](/filings/0001390777-26-000060.md) | [5.7](/filings/0001390777-26-000086.md) | [5.1](/filings/0001390777-25-000159.md) | [5.1](/filings/0001390777-26-000033.md) | [6.4](/filings/0001390777-26-000060.md) | [7.5](/filings/0001390777-26-000086.md) |
| Total assets | $bn | [405](/filings/0001390777-23-000103.md) | [410](/filings/0001390777-26-000033.md) | [435](/filings/0001390777-24-000075.md) | [429](/filings/0001390777-24-000105.md) | [427](/filings/0001390777-24-000133.md) | [416](/filings/0001390777-26-000033.md) | [441](/filings/0001390777-25-000084.md) | [486](/filings/0001390777-25-000118.md) | [455](/filings/0001390777-25-000159.md) | [472](/filings/0001390777-26-000086.md) | [562](/filings/0001390777-26-000060.md) | [525](/filings/0001390777-26-000086.md) |
| Total liabilities | $bn | [364](/filings/0001390777-23-000103.md) | [369](/filings/0001390777-25-000046.md) | [394](/filings/0001390777-24-000075.md) | [387](/filings/0001390777-24-000105.md) | [385](/filings/0001390777-24-000133.md) | [374](/filings/0001390777-26-000033.md) | [397](/filings/0001390777-25-000084.md) | [441](/filings/0001390777-25-000118.md) | [411](/filings/0001390777-25-000159.md) | [427](/filings/0001390777-26-000086.md) | [516](/filings/0001390777-26-000060.md) | [480](/filings/0001390777-26-000086.md) |
| Long-term debt | $bn | [29.2](/filings/0001390777-23-000103.md) | [31.3](/filings/0001390777-25-000046.md) | [32.4](/filings/0001390777-24-000075.md) | [30.9](/filings/0001390777-24-000105.md) | [33.2](/filings/0001390777-24-000133.md) | [30.9](/filings/0001390777-26-000033.md) | [30.9](/filings/0001390777-25-000084.md) | [33.4](/filings/0001390777-25-000118.md) | [32.3](/filings/0001390777-25-000159.md) | [31.9](/filings/0001390777-26-000086.md) | [32.6](/filings/0001390777-26-000060.md) | [30.4](/filings/0001390777-26-000086.md) |
| Short-term borrowings | $bn | not reported | [0.0](/filings/0001390777-25-000046.md) | not reported | [0.3](/filings/0001390777-24-000105.md) | [0.3](/filings/0001390777-24-000133.md) | [0.3](/filings/0001390777-26-000033.md) | [1.7](/filings/0001390777-25-000084.md) | [2.4](/filings/0001390777-25-000118.md) | [2.4](/filings/0001390777-25-000159.md) | [2.0](/filings/0001390777-26-000086.md) | [1.0](/filings/0001390777-26-000060.md) | [4.8](/filings/0001390777-26-000086.md) |
| Shareholders' equity | $bn | [41.0](/filings/0001390777-23-000103.md) | [40.8](/filings/0001390777-25-000046.md) | [40.6](/filings/0001390777-24-000075.md) | [40.8](/filings/0001390777-24-000105.md) | [42.0](/filings/0001390777-24-000133.md) | [41.3](/filings/0001390777-26-000033.md) | [43.1](/filings/0001390777-25-000084.md) | [44.0](/filings/0001390777-25-000118.md) | [43.9](/filings/0001390777-25-000159.md) | [44.3](/filings/0001390777-26-000086.md) | [44.8](/filings/0001390777-26-000060.md) | [44.7](/filings/0001390777-26-000086.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [5,040 d](/filings/0001390777-24-000133.md) | [(2,068) d](/filings/0001390777-26-000033.md) | [(2,680)](/filings/0001390777-25-000084.md) | [2,129 d](/filings/0001390777-25-000118.md) | [(312) d](/filings/0001390777-25-000159.md) | [1,550 d](/filings/0001390777-26-000033.md) | [412](/filings/0001390777-26-000060.md) | [2,197 d](/filings/0001390777-26-000086.md) | [(1,064) d](/filings/0001390777-25-000159.md) | [5,185 d](/filings/0001390777-26-000033.md) | [(3,013)](/filings/0001390777-26-000060.md) | [2,462 d](/filings/0001390777-26-000086.md) |
| Capital expenditure | $m | [336 d](/filings/0001390777-24-000133.md) | [269 d](/filings/0001390777-26-000033.md) | [299](/filings/0001390777-25-000084.md) | [382 d](/filings/0001390777-25-000118.md) | [375 d](/filings/0001390777-25-000159.md) | [413 d](/filings/0001390777-26-000033.md) | [320](/filings/0001390777-26-000060.md) | [359 d](/filings/0001390777-26-000086.md) | [438 d](/filings/0001390777-25-000159.md) | [436 d](/filings/0001390777-26-000033.md) | [617](/filings/0001390777-26-000060.md) | [487 d](/filings/0001390777-26-000086.md) |
| Dividends paid | $m | [333 d](/filings/0001390777-24-000133.md) | [328 d](/filings/0001390777-26-000033.md) | [324](/filings/0001390777-25-000084.md) | [322 d](/filings/0001390777-25-000118.md) | [353 d](/filings/0001390777-25-000159.md) | [349 d](/filings/0001390777-26-000033.md) | [343](/filings/0001390777-25-000084.md) | [346 d](/filings/0001390777-25-000118.md) | [381 d](/filings/0001390777-25-000159.md) | [377 d](/filings/0001390777-26-000033.md) | [434](/filings/0001390777-26-000060.md) | [453 d](/filings/0001390777-26-000086.md) |
| Share repurchases | $m | [450 d](/filings/0001390777-24-000133.md) | [450 d](/filings/0001390777-26-000033.md) | [988](/filings/0001390777-25-000084.md) | [601 d](/filings/0001390777-25-000118.md) | [725 d](/filings/0001390777-25-000159.md) | [750 d](/filings/0001390777-26-000033.md) | [746](/filings/0001390777-26-000060.md) | [895 d](/filings/0001390777-26-000086.md) | [849 d](/filings/0001390777-25-000159.md) | [1,045 d](/filings/0001390777-26-000033.md) | [983](/filings/0001390777-26-000060.md) | [1,103 d](/filings/0001390777-26-000086.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock, us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [791](/filings/0001390777-24-000105.md) | [782](/filings/0001390777-24-000133.md) | [772](/filings/0001390777-24-000075.md) | [762](/filings/0001390777-25-000084.md) | [752](/filings/0001390777-25-000118.md) | [742](/filings/0001390777-25-000159.md) | [734](/filings/0001390777-25-000084.md) | [727](/filings/0001390777-26-000060.md) | [720](/filings/0001390777-26-000086.md) | [713](/filings/0001390777-25-000159.md) | [698](/filings/0001390777-26-000060.md) | [692](/filings/0001390777-26-000086.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 678,504,142 at 2026-06-30, from the cover of the [10-Q filed 2026-07-31](/filings/0001390777-26-000086.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.